|
1
|
Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.
|
Clin Cancer Res
|
2005
|
2.65
|
|
2
|
Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients.
|
Eur J Cancer
|
2011
|
1.51
|
|
3
|
Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast.
|
Cancer
|
2005
|
1.47
|
|
4
|
Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.34
|
|
5
|
Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite Registry Trial.
|
Cancer
|
2010
|
1.17
|
|
6
|
Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2.
|
Int J Cancer
|
2002
|
1.16
|
|
7
|
Genetic predictors of adverse radiotherapy effects: the Gene-PARE project.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.10
|
|
8
|
Correlates and determinants of nuclear epidermal growth factor receptor content in an oropharyngeal cancer tissue microarray.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.09
|
|
9
|
Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.06
|
|
10
|
p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage.
|
Cancer Res
|
2011
|
1.03
|
|
11
|
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.
|
PLoS Med
|
2009
|
0.99
|
|
12
|
Postchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer.
|
Cancer J
|
2006
|
0.95
|
|
13
|
Outcome after ipsilateral breast tumor recurrence in patients who receive accelerated partial breast irradiation.
|
Cancer
|
2012
|
0.94
|
|
14
|
Five-year outcome of patients classified in the "unsuitable" category using the American Society of Therapeutic Radiology and Oncology (ASTRO) Consensus Panel guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite® Registry trial.
|
Ann Surg Oncol
|
2010
|
0.88
|
|
15
|
Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial.
|
Am J Surg
|
2005
|
0.88
|
|
16
|
Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ.
|
Eur J Cancer
|
2005
|
0.85
|
|
17
|
Tumor bed control with balloon-based accelerated partial breast irradiation: incidence of true recurrences versus elsewhere failures in the American Society of Breast Surgery MammoSite(®) Registry Trial.
|
Ann Surg Oncol
|
2012
|
0.83
|
|
18
|
Improvement in dose homogeneity with electronic tissue compensation over IMRT and conventional RT in whole brain radiotherapy.
|
Radiother Oncol
|
2008
|
0.82
|
|
19
|
Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer.
|
Breast Cancer Res Treat
|
2006
|
0.81
|
|
20
|
Object-constrained meshless deformable algorithm for high speed 3D nonrigid registration between CT and CBCT.
|
Med Phys
|
2010
|
0.80
|
|
21
|
Axillary failure in patients treated with MammoSite accelerated partial breast irradiation.
|
Ann Surg Oncol
|
2011
|
0.77
|
|
22
|
A 3D global-to-local deformable mesh model based registration and anatomy-constrained segmentation method for image guided prostate radiotherapy.
|
Med Phys
|
2010
|
0.77
|
|
23
|
Riluzole is a radio-sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells.
|
Pigment Cell Melanoma Res
|
2014
|
0.77
|
|
24
|
Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells.
|
Pigment Cell Melanoma Res
|
2014
|
0.77
|
|
25
|
Improved treatment of pelvis and inguinal nodes using modified segmental boost technique: dosimetric evaluation.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.76
|
|
26
|
Intersociety Radiation Oncology Summit-SCOPE II.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.75
|
|
27
|
Sequential high-dose alkylating therapy and stem cell support for high-risk stage III breast cancer.
|
Breast J
|
2003
|
0.75
|
|
28
|
A clinical objective IMRT QA method based on portal dosimetry and electronic portal imager device (EPID) measurement.
|
Technol Cancer Res Treat
|
2012
|
0.75
|
|
29
|
Has placement of surgical clips in the lumpectomy bed fallen out of favor?
|
Ann Surg Oncol
|
2011
|
0.75
|